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The recruitment of leukocytes to sites of inflammation is crucial for a functional immune response. In the present work, we ex-
plored the role of mitochondria in lymphocyte adhesion, polarity, andmigration. We show that during adhesion to the activated
endothelium under physiological flow conditions, lymphocyte mitochondria redistribute to the adhesion zone together with the
microtubule-organizing center (MTOC) in an integrin-dependent manner. Mitochondrial redistribution and efficient lympho-
cyte adhesion to the endothelium require the function of Miro-1, an adaptor molecule that couples mitochondria to microtu-
bules. Our data demonstrate that Miro-1 associates with the dynein complex. Moreover, mitochondria accumulate around the
MTOC in response to the chemokine CXCL12/SDF-1; this redistribution is regulated byMiro-1. CXCL12-dependent cell polar-
ization andmigration are reduced inMiro-1-silenced cells, due to impaired myosin II activation at the cell uropod and dimin-
ished actin polymerization. These data point to a key role of Miro-1 in the control of lymphocyte adhesion andmigration
through the regulation of mitochondrial redistribution.
The recruitment of blood leukocytes to the site of inflammationinvolves a sequential, multistep adhesion cascade between the
leukocyte and endothelial cell adhesion molecules that mediates
leukocyte rolling, firm adhesion, and transmigration across the
endothelium (1). Firm arrest of leukocytes on endothelial cells is
mediated by the interaction of leukocyte integrins, mainly very
late antigen 4 (VLA-4) (41) and lymphocyte function-associ-
ated antigen 1 (LFA-1) (L2), with their respective endothelial
counterreceptors vascular cell adhesion molecule 1 (VCAM-1)
and intercellular adhesion molecule 1 (ICAM-1) (2). During this
process, the leukocyte and endothelium cytoskeletons undergo an
extensive reorganization that ensures sufficient duration of the
contact and enables leukocyte extravasation. Leukocyte naviga-
tion through tissues is governed by extracellular signals, such as
chemoattractant gradients (chemotaxis) and adhesion signals.
Chemokines, by activating specific receptors of the G-protein-
coupled receptor (GPCR) family, generate leukocyte polarity by
inducing the formation of a leading edge (through actin polymer-
ization) and a uropod, a slender posterior appendage character-
ized by actin-myosin-driven contraction (3, 4).
Mitochondria are highly dynamic organelles that continuously
remodel their shape and size through fission and fusion events.
They are actively relocalized within the cell through a cytoskele-
ton-based transportation system (5). These organellesmove along
microtubules in both anterograde and retrograde directions, us-
ing kinesin and dynein motor proteins, respectively (6). Specific
subcellular locations with high energy and Ca2-buffering re-
quirements, such as cellular synapses and other polarized struc-
tures, require the establishment of a high local density of mito-
chondria (7, 8). In leukocytes, mitochondria relocalize to the
uropod during chemotaxis (9) and to the immune synapse (IS) to
enable modulation of its architecture and downstream signaling
(10–12). The molecular mechanisms driving this mitochondrial
positioning to specific subcellular locations in lymphocytes are,
however, not well understood.
It has been reported that the atypical RhoGTPaseMiro-1 plays
an essential role in the regulation of mitochondrial morphogene-
sis and trafficking along microtubules (13, 14) and might serve as
a calcium-dependent sensor for the control of mitochondrial mo-
tility (15–17). Miro-1 binds the cytoplasmic adaptor protein mil-
ton and kinesin heavy chain through its cytoplasmic domains,
thereby connecting mitochondria to microtubules (18). Miro-1
contains a transmembrane domain that anchors it to the outer
mitochondrial membrane, two GTPase domains, and two Ca2-
sensing EF-hand domains that protrude into the cytoplasm (14).
Upon binding of Ca2 to its EF-hand domains,Miro-1 dissociates
from microtubules (19). The expression of a Miro-1 form with a
double mutation in its EF-hands prevents the arrest of mitochon-
dria in response to cytoplasmic Ca2 elevation (15–17) and de-
creases the level of Ca2 entering mitochondria (20).
Here we show that the lymphocyte mitochondria specifically
redistribute to the adhesion zone in close contact with the endo-
thelium. Our results indicate that Miro-1, through the regulation
of mitochondrial movement along microtubules and its associa-
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tion with dynein/dynactin motors, influences mitochondrial po-
sitioning. Deficiency in Miro-1 prevents correct interaction with
inflamed endothelium, lymphocyte polarization, and chemotactic
migration.
(Giulia Morlino conducted this study in partial fulfillment of
the requirements for a Ph.D. in Molecular Medicine, Program in
Basic and Applied Immunology, San Raffaele University, Milan,
Italy.)
MATERIALS AND METHODS
Cells, plasmids, and cell transfection.Human umbilical vein endothelial
cells (HUVEC) were obtained and cultured as previously described (21).
To activate HUVEC, tumor necrosis factor alpha (TNF-) (20 ng/ml;
R&D Systems) was added to the culture medium 20 h before adhesion/
migration assay. Human peripheral blood lymphocytes (PBLs) and T
lymphoblasts were obtained and cultured as described elsewhere (22).
CEM T cells, CH7C17 T cells, and the human erythroleukemic cell line
K562 stably overexpressing 4 or L integrin were grown in RPMI 1640
medium (GIBCO BRL) supplemented with 10% fetal calf serum (FCS)
(Invitrogen), 50 IU/ml penicillin, and 50 g/ml streptomycin. Medium
for CH7C17 cells was further supplemented with 400 g/ml hygromy-
cin B and 4 g/ml puromycin, and medium for K562 was further
supplemented with 1 mg/ml G418. The HEK293T cell line was cul-
tured in Dulbecco modified Eagle medium (DMEM) (Sigma) supple-
mented with 10% FCS.
Plasmids encoding fluorescence-tagged ICAM-1 proteins (green flu-
orescent protein [GFP], yellow fluorescent protein [YFP], and cyan fluo-
rescent protein [CFP])were described previously (23). Plasmids encoding
mitochondrion-targeted dsRED (mtRFP) ormtYFP (24) were generously
provided by L. Scorrano (University of Padua, Italy). The EB1-GFP con-
struct was a kind gift from Anna Akhmanova (Utrecht University, The
Netherlands). The GFP-Miro construct was a gift from J. T. Kittler (Uni-
versity College London); the double K208 K328 Miro-1 mutation (Miro-
1KK) was generated by site-directed mutagenesis with the QuikChange
protocol (Stratagene). Small interfering RNAs (siRNAs) against human
dynein heavy chain (DHC) were previously described (25); those against
Miro-1 were a SMARTpool of 4 distinct siRNAs (5=-GCUUAAUCGUAG
CUGCAAA-3=, 5=-CCAGAGAGGGAGACACGAA-3=, 5=-GCAAUUAG
CAGAGGCGUUA-3=, and 5=-UGUGGAGUGUUCAGCGAAA-3=) ob-
tained, together with the negative-control siRNA (5=-AAUUCUCCGAA
CGUGUCACGUdTdT-3=), from Thermo Scientific Dharmacon. T-cell
lines, human T lymphoblasts, and HUVEC were transfected with DNA
plasmids or with specific double-stranded siRNAs by electroporation us-
ing the Gene Pulser II electroporation system (Bio-Rad Laboratories) or
the Nucleofector system (Amaxa Biosystems). HEK293T cells were trans-
fected using Lipofectamine (Invitrogen). CEMT cells were electroporated
twice (at 0 and 72 h) with specific siRNA at a final concentration of 2M.
The efficiency of gene silencingwas checked byWestern blotting, and cells
were used for experiments on day 6 after the first electroporation. Tran-
siently transfected HUVEC were used at 24 to 48 h after transfection.
Reagents and antibodies. Recombinant human fibronectin (FN),
poly-L-lysine (PLL), human gamma globulin, oligomycin, fluorescein iso-
thiocyanate (FITC)-conjugated or unconjugated anti--tubulin, and anti-
DHC (clone 440) were from Sigma-Aldrich. The mitochondrial calcium
uptake inhibitor Ru360 and antibiotic G418 were from Calbiochem. The
fluorescent cell tracker BCECF-AM, Alexa Fluor 488, and 647 phalloidin
conjugates, JC-1, Fluo4-AM, Mitotracker Orange, Mitotracker Green,
DiO, DiD, and Dil Vybrant cell labeling solutions, and all fluorochrome-
conjugated secondary antibodies were from Invitrogen. Puromycin was
from InvivoGen and hygromycin B from Roche. PureCol (Advanced
BioMatrix) (3 mg ml1) and bovine collagen I (GIBCO) were employed
for standard collagen assays and for collagen titration experiments, re-
spectively. The antibodies D3/9 (anti-CD45), HP 2/6 (anti-CD4), HP2/1
(anti-4 integrin), and TS1/11 (anti-L integrin) were produced in our
laboratory (23). TP 1/25 (anti-ICAM-3) and TS2/16 (anti-1 integrin)
antibodies were described previously (21, 26). Hu5/3 antibody (anti-
ICAM-1) was kindly provided by F. W Luscinskas (Brigham andWomen
Hospital, Boston, MA). Polyclonal antibody against ezrin/moesin (90/3)
was provided by Heinz Furthmayr (Stanford University, Stanford, CA).
The rabbit polyclonal anti-Mn-superoxide dismutase (anti-MnSOD) an-
tibody was from Rockland. Anti-extracellular signal-regulated kinase 1/2
(anti-ERK1/2) and anti-p74 were from Millipore; phospho-ERK1/2 and
anti-pSer19myosin light chain (MLC) were fromCell Signaling Technol-
ogy; monoclonal p50-dynamitin, anti-p150glued, and anti-CXCR-4 were
from BD Transduction Laboratories; and anti-GFP was from Living Col-
ors (Clontech Laboratories, Inc.). Anti-Miro-1 for Western blotting was
from Abnova and that for immunoprecipitation (IP) from Abcam. Anti-
dynein heavy chain antibody was from Santa Cruz. Antigiantin was from
Abcam. Horseradish peroxidase (HRP)-conjugated secondary antibodies
were from Pierce. Recombinant human CXCL12 was from ImmunoTo-
ols. Integrin inhibitors BIO5192 and BIRT377 were provided by Biogen
Idec and Boehringer Ingelheim, respectively (27).
Fluorescence confocal microscopy. For immunofluorescence assays,
lymphocytes were plated on slides coated with PLL or FN or on confluent
HUVEC for 20 min at 37°C, fixed with 4% paraformaldehyde (PFA)
(Electron Microscopy Sciences), stained with the indicated antibodies,
and mounted in Prolong (Invitrogen). Where indicated, the PLL or FN
matrix included 10 nM CXCL12. To detect intracellular proteins, cells
were permeabilized for 3 min with 0.2% Triton X-100 in phosphate-
buffered saline (PBS) before staining. Confocal imageswere obtainedwith
a Leica TCS-SP5 confocal scanning laser unit with an inverted epifluores-
cence microscope (DMI6000B). Microscopes were maintained at 37°C
with 5%CO2 and covered by a full acrylic box, allowing live-cell imaging.
For time-lapse fluorescence imaging, cells were plated onto coated 35-mm
dishes (MatTek).
Redistribution of lymphocyte mitochondria toward the endothelium
was calculated as percentage of the fluorescence intensity (FI) of lympho-
cytemitochondria located in the third of the cell near theHUVEC contact
area. FI was measured using ImageJ or Metamorph. Cellular polarity was
assessed by the elliptical form factor, calculated from images with mem-
brane protein staining using Metamorph software. The phosphorylated
myosin light-chain (pMLC) concentration at the uropod with respect to
the leading edge and the three-dimensional distance between the mito-
chondrial network and the microtubule-organizing center (MTOC) were
quantified using the Fluorescence Ratio and Distance Measure plug-ins
for ImageJ, respectively.
Calcium measurement. For measurement of intracellular Ca2 flux,
control and Miro-1-silenced CEM cells were preincubated with DiD and
Dil, respectively, to distinguish them. The pooled cells were loaded with
Fluo-4-AM (12) and settled ontoMatTek glass-bottom dishes covered by
a TNF--activated HUVECmonolayer. Images were acquired every 10 s,
using a TCS SP5 confocal microscope. The mean Fluo-4 fluorescence
intensity of each migrating cell in each frame was calculated by Wimasis
GmbH. Calcium peak intensity was calculated by subtracting the basal
fluorescence intensity from the maximum fluorescence registered in each
peak. Peak duration was calculated by multiplying the number of frames
in which it was registered by frame duration in seconds.
Fluorescence image analysis. Imageswere analyzedwith Leica LASAF
(Leica Microsystems), Metamorph (Universal Imaging Corporation,
Downingtown, PA), or ImageJ (NIH) software. Mitochondria and
MTOC three-dimensional (3D) reconstructions were obtained using
Imaris 7.6 software (Bitplane).
Fluorescence ratios. To measure the relative fluorescence between
two regions, we computed the ratio between the average fluorescence in
the two areas corrected for background fluorescence according to the
followingmodel. Themodel assumes that the observed fluorescence in the
different areas can bemodeled as the contribution of background fluores-
cence (Bg), fluorescence in region of interest A (A), and fluorescence in
region of interest B (B):
Miro-1 Controls Lymphocyte Migration and Polarity
April 2014 Volume 34 Number 8 mcb.asm.org 1413
 o
n
 August 8, 2014 by Red de Bibliotecas del CSIC
http://m
cb.asm
.org/
D
ow
nloaded from
 

Bgobs
Aobs
Bobs
 
1 0 0
1 1 1
1 0 1

Bg
A
B

In the model, fluorescence observed in region A is the sum of the
background fluorescence and the fluorescences of regions A and B, while
the fluorescence observed in region B is the contribution of the back-
ground fluorescence and the fluorescence of region B.
Background-corrected contributions can be estimated by inverting
the model:

Bg
A
B
 
1 0 0
0 1 1
1 0 1

Bgobs
Aobs
Bobs

Note that the estimated A and B have already been corrected for the
background fluorescence and that A no longer has a contribution from
region B (it is the pure contribution of region A). Finally, we compute the
relative fluorescence ratio as r (A B)/B.
Distancemeasurements.Tomeasure the distance between two three-
dimensional fluorescence distributions in independent channels, we
binarized both gray-scale stacks (the user can select two thresholds so that
the region of interest is isolated in both channels). We then computed the
Euclidean distance between every possible pair of voxels (one in distribu-
tion A and the other in distribution B). This gives us the exact distribution
of pairwise distances. Note that the calculation is fully computed in 3D
and therefore that the actual distance between the two regions of interest
is calculated. Finally, we computed a truncated mean by computing the
distancemean after discarding the 5% lower and upper values. This mean
is known to be a robust estimate of the distribution mean.
TIRFM. For total internal reflection fluorescence microscopy
(TIRFM), control and Miro-1-silenced CEM cells, transfected with EB1-
mGFP, were sorted to warrant transfection and cultured for 24 h. Cells
were allowed to settle onto FN-coated glass-bottommicrowell dishes (no.
1.5; Mattek, Ashland, MA, USA). Recording was initiated 3 min after cell
plating, and cells were visualized with a Leica AM TIRF MC M mounted
on a Leica DMI 6000B microscope coupled to an Andor-DU8285_VP-
4094 camera. Images were acquired with an HCX PL APO 100.01.46 oil
objective and processed with the accompanying confocal software (LCS;
Leica) as described previously (28). For EB1-GFP microtubule plus tip
tracking, penetrance was 150 nm for the 488-nm laser channel with same
objective angle and a 0.26-s exposure time. Synchronization was per-
formed through the Leica software. Images were analyzed and converted
intomovies using Imaris software (Bitplane, Switzerland). Quantification
of the number of microtubule nucleation events, tracking of microtubule
movement trajectories, and computation of microtubule growth were
performed with the “connected components” algorithm for particle
tracker. EB1-GFP comets were detected by the surface algorithm detec-
tion based on channel intensity and using a local background. Analysis
was conducted onmovie lengths of 300 s that were captured at a rate of 0.5
frame/s. To exclude microtubules that move in and out of the z plane,
events shorter than 2 m were not incorporated into the final analysis.
Ligand-coated microspheres. Styrene divinylbenzene latex beads
(6-m diameter; Sigma) were coated with VCAM-1-Fc or ICAM-1-Fc,
produced in our laboratory (29). CH7C17 cells preloaded with Mito-
tracker Orange (2  105) were mixed with precoated latex beads (2 
105), incubated for 30 min at 37°C in Hanks balanced salt solution
(HBSS)–2% bovine serum albumin (BSA), and plated on FN-coated
slides. Slides were fixed and immunostained for tubulin. Redistribution of
mitochondria and MTOC was considered to have occurred if they were
more abundant in the third of the cell centered on the contact with the
latex bead.
Immunoblotting and coimmunoprecipitation. After the indicated
treatment, CEM and CH7C17 T cells were lysed as described previously
(12). For coimmunoprecipitation assays, transfected HEK293T cells or
primary T lymphoblasts were lysed in ice-cold lysis buffer containing
0.5% Triton X-100 as described previously (14). Lysates were centrifuged
at 16,000  g for 10 min at 4°C, and the resulting supernatants were
precleared for 1 h at 4°C with protein G Dynabeads (Life Technologies)
and incubated for 3 h with anti-GFP or with anti-Miro-1. Immunocom-
plexeswere collected by incubationwith proteinGDynabeads for 1 h. The
samples were thereafter washed six times with ice-cold lysis buffer and
processed for Western blotting. Proteins were separated by SDS-PAGE
and visualized with Fujifilm LAS-3000 after membrane incubation with
specific primary antibodies and peroxidase-conjugated secondary anti-
bodies. Band intensities were quantified using Image Gauge software
(Fujifilm) and results normalized to-tubulin or, for phosphoproteins, to
total protein expression.
Parallel-plate flow chamber analysis of endothelial cell-leukocyte
interactions and detachment. PBLs, T lymphoblasts, peripheral blood
mononuclear cells (PBMCs), and CEM cells (1  106/ml) were drawn
across activated confluent HUVEC monolayers at an estimated shear
stress of 1.8 dynes (dyn)/cm2 (assumed as physiological for human post-
capillary venules where transmigration takes place) for the required time.
The shear stress was applied as described previously (23).
Control and Miro-1-silenced CEM cells were first labeled with DiO,
Dil, or Did and then with Mitotracker Orange or Green. Cells (106/ml
fromeach type)were drawn across on activated confluentHUVECmono-
layers with a shear stress of 1.8 dyn/cm2. Images were acquired every 30 s.
Cells labeled with different cell trackers or Mitotrackers displayed similar
results, confirming that there was no interference with the cellular pro-
cesses analyzed.
For detachment experiments, control and Miro-1-silenced CEM cells
were preincubated withMitotracker Orange or Green to distinguish them
and allowed to adhere for 5min at 37°C to activatedHUVECmonolayers.
Shear stress was started at 0.5 dyn/cm2 and increased up to 15 dyn/cm2.
Cell detachment was calculated by normalizing the number of adhered
cells to the number observed at the flow rate of 0.5 dyn/cm2.
Adhesion assays.HUVEC were grown to confluence in 96-microwell
plates (Costar) and activated with TNF-. CEM or CH7C17 cells were
labeledwith 1MBCECF-AMand adhered to the activatedHUVEC (21).
In other experiments, CEM cells (1  106/ml) were left untreated or
pretreated with 4 M oligomycin or 10 MRu360 (30 min) and washed
and resuspended in HBSS–2% FCS. The cells were then adhered to acti-
vated HUVEC in 6-well plates for 30 min at 37°C under static conditions
or with continuous rotation (60 rpm). After incubation, the plates were
washed three times withHBSS, and adhered cells were fixedwith 4%PFA.
The effects of inhibitors on lymphocyte adhesion were assessed by count-
ing the number of adhered cells using the CellCounter ImageJ plug-in.
Results were normalized to those for untreated cells adhered to activated
HUVEC. Cells adhered to nonactivated HUVEC were used as a negative
control.
Migration and transmigration assays. Migration assays were per-
formed in 5-m-pore-size Transwell cell culture chambers (Costar) (30).
Transmigration through a confluent monolayer of activated HUVECwas
assayed in 5-m-pore-size Transwell plates (23). The number ofmigrated
cells was measured by flow cytometry.
3Dmigration assay.Migration of CEM T cells through a 3D collagen
matrix was assayed according to the manufacturer’s instructions (Ibidi).
Control and Miro-1-silenced CEM cells were preincubated with DiD
or Dil, and images were acquired every 5 min for standard assays (see
Fig. 4C) and every 3 min for titration experiments (see Fig. 4D). Im-
ages were analyzed using the Manualtracking and Chemotaxis Tool
ImageJ plug-ins.
F-actin determination. Levels of polymerized actin were measured as
described previously (31). Briefly, cells (1 105 perwell of a 96-well plate)
were incubated with 10 nMCXCL12 at 37°C for the indicated times. Cells
were then fixed, permeabilized, and stained with phalloidin-Alexa Fluor
647 (Invitrogen). Fluorescence intensity was determined in a FACSCanto
flow cytometer (BD Biosciences) and analyzed with Flow-Jo software.
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Results are expressed as the fold increase in mean fluorescence intensity
relative to that of the cells not exposed to CXCL12.
Flow cytometry calcium measurement. To track intracellular cal-
cium levels in cells in suspension, control andMiro-1-silenced CEM cells
were incubatedwithDiDorDil and Fluo4-AM, and after 1min of baseline
recording, CXCL12 was added (10 nM). Calcium flux was measured over
time using a FACSCanto flow cytometer. Ionomycin (0.5 mg/ml) was
used as a positive control. Data were analyzed with Flow-Jo software.
ATPmeasurement. For intracellular ATP quantifications, frozen cells
were homogenized with a lysis buffer (25 mM Tris-HCl [pH 7.5], 0.1%
Triton X-100), and ATP was rapidly measured by a coupled luciferin-
luciferase reaction (32) with an ATP determination kit (Invitrogen, Pais-
ley, United Kingdom). For protein quantification, a colorimetric method
(Pierce bicinchoninic acid [BCA] protein assay kit) was used following the
manufacturer=s instructions.
Mitochondrial membrane potential. The mitochondrion-directed
fluorescence-sensitive probe JC-1 was used to determine variations in
mitochondrialmembrane potential (	
m) (12). Briefly, CEMT cells (1
105 per well of a 96-well plate) were preloaded with JC-1 (2 mg/ml) and
stimulated with 10 nM CXCL12 at 37°C for the indicated times. FL1 (520
nm) and FL2 (590 nm) emissions were recorded in a FACSCanto flow
cytometer and analyzed with Flow-Jo software.
Statistical analysis. Statistical analysis and comparisons were made
with GraphPad Prism5. Data were tested for normality using the
D’Agostino-Pearson omnibus normality test or using the Kolmogorov-
Smirnov test when the sample was small due to experimental conditions.
Differences betweenmeans were tested by Student’s t test for normal data.
Datawere analyzed using one-way analysis of variance (ANOVA)with the
Bonferroni posttest (for Fig. 2D and 5D and for Fig. S4A in the supple-
mental material) and with the Tukey posttest (for Fig. 7D) or using two-
way ANOVA with the Bonferroni posttest (for Fig. 3D).
RESULTS
Mitochondrial positioning to the adhesion zone during leuko-
cyte-endothelial cell interaction. We first assessed the specific
redistribution of leukocyte mitochondria during the interaction
between leukocyte and endothelial cells. Using time-lapse confo-
cal microscopy, we tracked lymphocyte mitochondria, using mi-
tochondrion-targeted fluorescent proteins or with Mitotracker
Orange, during their interaction with TNF--activated primary
human umbilical vein endothelial cells (HUVEC). During static
adhesion of human T lymphoblasts to activated HUVEC, most
lymphocyte mitochondria localized to the leukocyte-HUVEC
contact zone. During subsequent polarization of the migrating
lymphoblast, we observed a further relocalization of mitochon-
dria toward the uropod (Fig. 1A; seeMovie S1 in the supplemental
material). The initial redistribution of mitochondria to the con-
tact zone during endothelial adhesion was also observed in the
T-cell line CEM under both static and flow conditions (Fig. 1B).
This biphasicmitochondrial repositioning, with initial concentra-
tion at the endothelial contact zone followed by polarization to the
uropod in migrating cells, was also seen under physiological flow
conditions and with freshly isolated leukocyte populations (see
Fig. S1A and B in the supplemental material). These data indicate
that redistribution ofmitochondria to the adhesion zone and later
to the uropod constitutes a cellular signature of the attachment of
leukocytes to endothelium and their subsequent migration.
Mitochondria bind microtubule-associated proteins (MAPs)
and move along the microtubule network (6). To monitor the
redistribution of themicrotubule-organizing center (MTOC) and
mitochondria in lymphocytes adhering to activated endothelium
(Fig. 1C), we transfected human T lymphoblasts with paxillin-
GFP (33) and mtRFP to simultaneously track the MTOC and
mitochondria (Fig. 1D). During lymphocyte adhesion, most lym-
phocytemitochondria and theMTOCmoved in a concerted fash-
ion to the contact zone with the endothelium (Fig. 1D). In the
reverse experiment, in which endothelial mitochondria were
tracked by labeling with mtYFP, we did not detect a significant
shift of position upon lymphocyte adhesion (Fig. 1E). Confocal
microscopy revealed that endothelial mitochondria colocalized
with tubulin but not with the actin cytoskeleton (see Fig. S1C in
the supplemental material). In addition, endothelial mitochon-
dria were not present at the docking structure (23) formed after
leukocyte arrest on the endothelium (see Fig. S1D in the supple-
mental material). These results indicate that mitochondrial redis-
tribution is a specific process in leukocytes during interactionwith
endothelium.
Mitochondrial redistribution depends on lymphocyte integ-
rin engagement. We next assessed whether mitochondrial relo-
calization to the contact zone with endothelium is dependent on
specific interactions between lymphocyte integrins and adhesion
molecules present on activated endothelium. For this, we added
lymphoblasts to resting or TNF--activated HUVEC and quanti-
fied mitochondrial density as the percentage of the total mito-
chondrial fluorescence intensity located in the contact area (the
third of the cell adjacent to the contact site) (Fig. 2A). Upon ad-
hesion to activated endothelial cells, about 60% of mitochondrial
fluorescence was present at the contact area, contrasting with 30%
upon adhesion to nonactivated endothelium (Fig. 2A). To dissect
the role of lymphocyte integrins, we incubated T lymphocytes
with beads coated with ICAM-1 or VCAM-1, the ligands of integ-
rins LFA-1 and VLA-4, respectively, or with BSA as a negative
control (Fig. 2B). Engagement of VLA-4 or LFA-1 by their specific
ligands significantly increased translocation of bothmitochondria
and MTOC. The translocation rates of both MTOC and mito-
chondria in response to VLA-4 engagement (with fold inductions
in comparison to BSA of 2.1 for MTOC and 1.65 for mitochon-
dria) were higher than those observed with LFA-1 (1.5 and 1.25,
respectively) (Fig. 2B and C). Furthermore, T lymphoblasts
treated with specific LFA-1 or VLA-4 inhibitors and added to
TNF--activated HUVEC showed a clear reduction in mitochon-
drial translocation in comparison to the untreated cells (Fig. 2D),
as assessed by mitochondrial fluorescence intensity localized at
the contact area with endothelium. These data demonstrate that
specific engagement of both VLA-4 and LFA-1 is sufficient to pro-
moteMTOC andmitochondrial translocation toward the cell-to-
cell contact during lymphocyte adhesion to endothelium.
Retrograde movement of mitochondria along microtubules
(toward the minus end, where MTOC is allocated) is mediated by
dynein (6). Cytoplasmic dynein is a multisubunit microtubule
motor complex that, together with its activator dynactin, drives
vesicular cargo toward the minus ends of microtubules (34). Spe-
cific silencing of dynein heavy chain (DHC) in T lymphocytes (see
Fig. S2A in the supplemental material) uncoupled mitochondria
from the MTOC and impaired the recruitment of both organelles
to the contact zone (see Fig. S2B in the supplemental material).
These cells showed an impaired ability to adhere to activated
HUVEC (see Fig. S2C in the supplemental material).
Miro-1 regulates mitochondrial redistribution and firm
lymphocyte adhesion to activated endothelium.Miro-1 is a cal-
cium-dependent sensor that controls mitochondrial motility
along microtubules and therefore mitochondrial trafficking (14–
17). We examined the possible involvement of Miro-1 in mito-
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chondrial translocation during lymphocyte adhesion. Depletion
of Miro-1 with a specific siRNA (Fig. 3A), which did not affect
Miro-2 expression (see Fig. S3A in the supplemental material),
decreased mitochondrial translocation in T cells adhered to acti-
vated HUVEC (Fig. 3B), suggesting that Miro-1 controls mito-
chondrial positioning in response to integrin engagement in T
cells. In contrast to DHC-silenced cells (see Fig. S2C), Miro-1-
depleted ones showed a slight but nonsignificant decrease of cell
adhesion under static conditions (Fig. 3C). A critical step during
lymphocyte interaction with the endothelium is firm adhesion.
Therefore, we analyzed the role of Miro-1 in firm adhesion by
measuring the resistance of T lymphocytes to be detached from
endothelium under increasing shear stress. Importantly, Miro-1-
silenced T cells detachedmore readily than controls fromHUVEC
FIG 1 Mitochondrial dynamics during leukocyte-endothelium interaction. (A) Representative images from a time-lapse videomicroscopy analysis of human T
lymphoblasts loaded with Mitotracker Orange (red) and adhered to a TNF--activated HUVEC monolayer transfected with ICAM-1–GFP (green). Maximal
projections of stacks near the endothelial monolayer are shown; dashed lines delineate cell contours of adhering lymphocytes, and arrowsmark sites of leukocyte
mitochondrial accumulation. Ad, adhered lymphocyte; LE, lymphocyte leading edge; U, lymphocyte uropod. (B) Time-lapse sequence of orthogonal maximal
projections of CEM T cells transfected with mtRFP (fluorescence intensity color gradient) adhering to an activated HUVEC monolayer transfected with
ICAM-1–YFP (gray scale). The graph shows the percentage of T-cell mitochondrial fluorescence intensity at the contact area (illustrated in the boxed region at
time zero, representing a third of the cell close to theHUVECmonolayer) during the adhesion, under flow conditions (1.8 dyn/cm2), of CEMcells. (C) Left panel,
representative horizontal and orthogonal sections of a lymphoblast adhered to an activated HUVEC monolayer. Cells were stained with anti-MnSOD (red),
anti-ICAM-1 (blue), and antitubulin-FITC (green). Right panel, histograms showing translocation of mitochondria and MTOC toward the contact zone in
human lymphoblasts adhered to activated HUVECmonolayers. Data are means standard deviation (SD) from two independent experiments (n 205 cells).
NS, nonsignificant difference. (D) Representative orthogonal maximal projections from a time-lapse sequence of a human T lymphoblast transfected with
paxillin-GFP (green) and mtRFP (red) adhering to an activated HUVEC monolayer (not shown); dashed lines delineate the cell contour of the adhering
lymphocyte. (E) Time-lapse sequence of a human PBL (asterisk) migrating toward an activated HUVEC monolayer transfected with mtYFP (yellow). Arrows
mark the endothelial area in contact with the PBL. Scale bars, 10 m.
FIG 2 Mitochondrial redistribution depends on integrin engagement. (A) Quantification of mitochondrial redistribution in lymphoblasts adhered to resting or
activated HUVEC monolayers. Mitochondrial redistribution is calculated as the percentage of mitochondrial fluorescence intensity (maximal Z-stack projec-
tions of Mitotracker Orange staining) located in the contact area with endothelial cells (defined as the third of the cell close to the HUVEC monolayer; see
scheme). Data are shown as a scatter plot; horizontal lines depict medians of 23 and 25 unpolarized cells adhered, respectively, on either TNF--activated or
nonactivated HUVEC. Three independent experiments were performed (***, P  0.001). The scheme illustrates the method used to quantify mitochondrial
redistribution. (B) Representative images of conjugates formed between CH7C17 cells and latex beads coated with BSA, ICAM-1, or VCAM-1, stained for
-tubulin (green) and mitochondria (red). DIC, differential interference contrast. Scale bars, 10 m. (C) Fold inductions, in comparison to a BSA negative
control, of MTOC andmitochondrial relocalization toward the coated beads. A minimum of 30 (BSA), 95 (VCAM-1), or 140 (ICAM-1) cells were analyzed for
each experiment. (D)Quantification ofmitochondrial redistribution in lymphoblasts untreated (n 43) and pretreated (15min at 37°C)with BIRT377 (n 41)
or BIO5192 (n 31) to block LFA-1 or VLA-4 integrins and incubated with activated TNF--activated HUVEC for 20 min. Data are shown as a scatter plot;
horizontal lines depict medians from two independent experiments of nonpolarized cells adhered to activatedHUVEC (***, P 0.001; **, P 0.01 [by one-way
ANOVA]).
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at a flow rate of 5 dyn/cm2 or above (Fig. 3D), suggesting a specific
role of Miro-1 in regulating the strength of lymphocyte adhesive-
ness. To explore the role ofMiro-1 in lymphocyte polarization, we
analyzed the shape of lymphocytes during adhesion to HUVEC
under flow conditions by measuring their elliptical form factor.
Interestingly, under these conditions, hyperpolarized cells were
present in control but not Miro-1-silenced cells (see Fig. S3 in the
supplemental material). We next investigated whether the defects
observed under physiological flow conditions both in firm adhe-
sion and polarization were accompanied by impaired mitochon-
drial dynamics. Miro-1-depleted cells presented an evident im-
paired ability to firmly adhere, polarize, andmigrate (seeMovie S2
in the supplemental material). Moreover, mitochondrial redistri-
bution to the uropod during polarization and the subsequent mi-
gration were greatly affected (Fig. 3E; see Movie S3 in the supple-
mental material).
Miro-1 knockdown impairs lymphocyte chemotaxis. To as-
sess whether Miro-1 regulates lymphocyte migration capability,
we examined CXCL12-inducedmigration of control andMiro-1-
silenced cells in modified Boyden chemotaxis chambers coated
with a TNF--activated HUVECmonolayer or uncoated. In both
cases,Miro-1-silenced cells migrated less efficiently along the che-
motactic gradient (Fig. 4A and B). Miro-1 knockdown also dis-
rupted the directionality and reduced the speed of T-cell migra-
tion toward CXCL12 in 3D collagen gels (Fig. 4C). These data
indicate that expression of Miro-1 is essential for proper direc-
tional lymphocyte migration in response to a chemotactic stimu-
lus not only under conditions greatly dependent on integrin func-
tion but also in an integrin-independentmigrationmode (35).We
further analyzed the contribution of Miro-1 during lymphocyte
migration within 3D gels containing different collagen concentra-
tions. Remarkably,Miro-1-silenced cellsmigrate slower than con-
trol cells through different collagen densities (Fig. 4D). It is note-
worthy that both control and Miro-1-depleted cells showed the
same trend in the decrease of mean velocity at increasing collagen
densities (35).
Miro-1 controlsCXCL12-mediated lymphocytepolarization
and mitochondrion-MTOC association. Chemokines can in-
crease lymphocyte adhesion to endothelium and also induce the
acquisition of a polarized, promigratory cell shape (36). CXCL12-
induced polarization was impaired in Miro-1-silenced cells
(Fig. 5A).
Upon Ca2 binding to its EF-hands, Miro-1 undergoes a con-
formational change resulting in the dissociation of mitochondria
from microtubule track (19). Therefore, we studied polarization
after CXCL12 stimulation in lymphocytes overexpressing GFP (as
a negative control), GFP-Miro, or GFP-MiroKK, a Miro-1 form
with the double mutation E208K E328K that is incapable of Ca2
binding in its EF motifs (14). The overexpression of Miro-1KK
with EF motif mutations was able to decrease CXCL12-induced
polarization (Fig. 5B; see Movie S4 in the supplemental material).
Moreover, we assessed the effect on CXCL12-mediated polariza-
tion of Miro-1KK overexpression in cells previously silenced for
Miro-1. As shown in Fig. S4A in the supplemental material, the
overexpression of GFP-Miro1KK did not restore cell polarity
whereas GFP-Miro1 rescued the phenotype observed in control
cells, underlining the importance of Miro-1 calcium binding do-
mains for its correct function in chemokine-induced lymphocyte
polarity.
We next assessed whether the defect in adhesion strength of
Miro-1-silenced cells as well as in polarization of both Miro-1-
silenced andMiroKK-expressing cells might be related to impaired
association ofmitochondria with theMTOC. For this, we plated T
cells on a fibronectin (FN) or poly-L-lysine (PLL) matrix contain-
ing CXCL12 and measured the distance between the center of
mass of mitochondrial fluorescence and the MTOC. In control
cells, CXCL12 stimulation reduced the distance between mito-
chondria and theMTOC at the uropod (Fig. 5C and D; see Movie
S5 in the supplemental material). This effect of CXCL12 was not
observed inMiro-1-silenced cells (Fig. 5C and D; see Fig. S4B and
Movie S5 in the supplemental material), supporting the impor-
tance ofMiro-1 in the relocalization of theMTOC andmitochon-
dria to the uropod.Moreover, T cells overexpressing GFP-MiroKK
showed a reduced proximity ofMTOCandmitochondria induced
by CXCL12 in comparison with T cells overexpressing GFP-Miro
(Fig. 5E and F; see Fig. S4C and Movie S6 in the supplemental
material). Upon chemokine stimulation,mitochondria first redis-
tribute toward the uropod (9) together with the MTOC. Our re-
sults indicate that Ca2 binding toMiro-1 EF-handsmight lead to
a conformational change in Miro-1, resulting in the halt of mito-
chondria in this specific subcellular location.
The effect of targeting Miro-1 by either silencing or GFP-
MiroKK was exerted specifically at the mitochondrion/MTOC po-
larized association, since other cell polarity parameters such as
membrane receptors or cytoskeletal proteins (ICAM-3 or ERM)
remained unaltered (see Fig. S4B and C in the supplemental ma-
terial).
To rule out possible pleiotropic effects produced by Miro-1
knockdown on the microtubular skeleton, we have assessed pa-
rameters such as the general conformation and dynamics of the
tubulin network and the localization of the Golgi apparatus (GA)
(37). Neither the tubulin network nor the GA was apparently al-
tered. Hence, the GA showed its usual localization around the
MTOC in both control and silenced cells (see Fig. S5A in the
FIG 3 Miro-1 regulates mitochondrial redistribution during adhesion and migration on endothelium. (A) Western blot analysis of siRNAMiro-1 silencing in
CEM T cells. (B) Box and whiskers plot (minimum to maximum) of mitochondrial redistribution in control and Miro-1-silenced cells adhered to TNF--
activated HUVEC monolayers. Mitochondrial redistribution is calculated as the percentage of mitochondrial fluorescence intensity located at the contact area
(defined as the third of the cell close to the HUVEC monolayer). Data are medians interquartile ranges for 247 (siCtrl) and 291 (siMiro-1) cells from three
independent experiments (***,P 0.001). (C)Quantification of lymphocyte adhesion on aTNF--activatedHUVECmonolayer in control andMiro-1-silenced
cells. Data are means  standard errors of the means (SEM) from three independent experiments. (D) Representative images of control CEM T cells (siCtrl;
Mitotracker Green) andMiro-1-silenced cells (siMiro; Mitotracker Orange) adhered to activated HUVEC under increasing shear stress (flow rate from 0.5 to 15
dyn/cm2). The right panel shows adhered cells at different flow rates as a proportion of adherence at 0.5 dyn/cm2. Data are from a representative experiment and
are the means  SEM for nine fields; **,*P  0.001 (by two-way ANOVA). (E) Representative images from time-lapse video microscopy of control and
Miro-1-silenced cells prestained with Mitotracker Orange and with DiO (siCtrl; green) and DiD (siMiro; blue) adhering and migrating on TNF--activated
HUVEC pretreated with CXCL12 (1 M) under physiological laminar flow conditions (1.8 dyn/cm2). The right part of each image shows the fluorescence
intensity distribution (gray values) across the cells (depicted by arrows). Scale bars, 10 m.
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supplemental material). Moreover, the analysis of microtubule
dynamics in control andMiro-1-silenced cells showed similarmi-
crotubule growth rates (siCtrl, 14.60 3.11 m · min1; siMiro,
15.01  2.82 m · min1) (see Fig. S5B and Movie S7 in the
supplemental material). Furthermore, membrane expression of
several cell markers, including integrins and the CXCL12 receptor
CXCR4, as well as the CXCL12-mediated endocytosis of CXCR4,
was largely unaffected (see Fig. S5C and D in the supplemental
material).
These results indicate thatMiro-1mediates mitochondrial po-
sitioning and MTOC association, a phenomenon specifically im-
plicated in the chemokine-induced acquisition of a polarized
morphology by lymphocytes.
Miro-1 associates with the dynein complex and contributes
to regulate CXCL12-induced lymphocyte activation. To investi-
gate how Miro-1 controls mitochondrial positioning, we trans-
fected HEK293T cells with GFP-Miro-1 or GFP alone and exam-
ined GFP immunoprecipitates from these cells. The dynein p74
intermediate chain and the dynactin p50 subunit were specifically
detected in GFP–Miro-1 immunoprecipitates (Fig. 6A). There-
fore, we analyzed this interaction in endogenous complexes from
human T lymphoblast lysates. Dynein heavy chain and the
p150glued component of dynactin were coimmunoprecipitated
with Miro-1 in these cells (Fig. 6A, right panel). Hence, Miro-1
appears to be a specific mediator of the interaction betweenmito-
chondria and the dynein/dynactin motor complex.
To explore the molecular basis of inhibited polarization in
Miro-1-silenced T cells, we studied molecular hallmarks of
chemokine-induced lymphocyte polarization. One of these hall-
marks is rapid actin polymerization (38), and we detected de-
creased actin polymerization in response to CXCL12 in Miro-1-
silenced cells (Fig. 6B and C). Another polarity hallmark in T cells
is myosin light-chain (MLC) phosphorylation, which is required
for efficient retraction of the uropod by myosin II (30). Interest-
ingly, CXCL12-induced MLC phosphorylation was inhibited in
the uropods of Miro-1-silenced cells (Fig. 6D), suggesting a spe-
cific role of Miro-1 in cell polarization.
We next examined the intracellular calcium dynamics in re-
sponse to CXCL12 stimulation and during lymphocyte migration
on activated endothelium. Interestingly, when cells were stimu-
lated with CXCL12 in suspension, we observed no significant dif-
ferences between control and Miro-1-silenced cells (Fig. 7A). In
contrast, when T cells adhered and migrated on activated endo-
thelium, Miro-1 depletion had a negative impact on the intensity
and duration of calciumpeaks (Fig. 7B andC). These data indicate
that Miro-1 regulates intracellular calcium not on a general scale
but in a subcellular context.
Mitochondrial activity is reflected in the electrical potential
(	
m) across the inner membrane and has a direct influence on
axonal transport (39). It has been shown that an increased 	
m
enhances the rate of mitochondrial transport, most obviously ret-
rograde movement (40). We found that CXCL12 increased 	
m,
but no significant differences were observed between the re-
sponses of control and Miro-1-silenced T cells (see Fig. S6 in the
supplemental material). Miro-1 depletion thus appears to affect
CXCL12-induced movement of mitochondria without signifi-
cantly affecting their intrinsic activation capacity. Moreover, to
rule out possible alterations in mitochondrial functioning due to
the downmodulation of Miro-1 expression, we assessed ATP cel-
lular content in both control and Miro-1-silenced cells. Control
andMiro-1-silenced cells had similar ATP contents, and CXCL12
stimulation led to a significant reduction in ATP levels in both
(Fig. 7D).
Chemokine receptors activate multiple signaling pathways,
leading to varied functional outcomes, including adhesion, polar-
ization, and chemotaxis (41). Among these, the ERK1/2 phos-
phorylation is one of most characterized cell signaling signatures
(42). Therefore, we assessed the role of Miro-1 in the modulation
of signaling downstream of the CXCL12 receptor through the
study of the phosphorylation kinetics of ERK1/2. Maximal
ERK1/2 phosphorylationwas detectedwithin 2min of chemokine
stimulation in control T cells, and this effect was clearly inhibited
in Miro-1-silenced cells (Fig. 7E).
DISCUSSION
In this study, we demonstrate that mitochondria relocalize to the
contact area during lymphocyte adhesion to endothelialmonolay-
ers and that this is directed by the GTPase Miro-1. Redistribution
of mitochondria is specific to leukocytes and is not observed in
endothelial cells. The movement of mitochondria involves the
LFA-1/ICAM-1 and VLA-4/VCAM-1 receptor/counterreceptor
pairs.
It has been reported that the MTOC and mitochondria can be
recruited by chemokine-activated LFA-1 at the immunological
synapse (43). Here, we provide evidence that the signal generated
by VLA-4 is even more efficient in the redistribution of both
MTOC and mitochondria. In our model, mitochondrial arrest in
the cellular zone of integrin engagement might be related to local
actin polymerization and increased intracellular Ca2. The cyto-
plasmic tail of the 4 subunit of VLA-4 interacts with paxillin
(44), which is a docking protein for other cytoskeletal proteins
such as F-actin, for tyrosine kinases, and for GTPase-activating
proteins (45). Moreover, VLA-4 engagement can promote the ty-
rosine phosphorylation of a broad range of proteins, including
proline-rich tyrosine kinase 2 (Pyk2), focal adhesion kinase
(FAK), and c-Src (46), resulting in the activation of several path-
ways. Accordingly, increased intracellular Ca2 and LFA-1 en-
gagement triggers activation and redistribution of Pyk2 to the
MTOC in T lymphoblasts (47). All these signaling cascades might
FIG 4 Miro-1 controls lymphocyte migration and chemotaxis. (A) Quantification of the transmigration of control and Miro-1-silenced CEM T cells across
Transwell filters (5-m pore size) coated with a TNF--activated HUVEC monolayer (see Materials and Methods). Data are expressed as a percentage with
respect to transmigrated control cells. (B) Migration of control and Miro-1-silenced CEM T cells across uncoated Transwell filters. Migration is calculated as a
percentage of input cells. Data in panels A and B are means SEM for two independent experiments run by duplicate (***, P 0.001; **, P 0.01). (C) Cell
trajectory plots of control and Miro-1-silenced cells migrating toward CXCL12 in a collagen matrix (1.6 mg ml1). The upper panels show results from a
representative experiment out of three. The lower panels show quantification of movement toward the chemokine (Y forward migration index) and cell speed
(mmin1) of 98 control and 102Miro-1-silenced cells from three independent experiments (mean SEM; ***, P 0.001). (D) Velocities of single migrating
control and Miro-1-silenced CEM cells (dots) in collagen gels with various densities. Data are shown as a scatter plot; horizontal lines depict means from three
independent experiments (***, P 0.001; **, P 0. 01).
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be involved in the confinement ofmitochondria andMTOCat the
contact zone.
The regulation of the interaction of mitochondria with the
cytoskeleton is crucial for proper mitochondrial function at spe-
cific sites of action (6). In our search for a specific adaptor between
mitochondria and microtubules, we focused on Miro-1, a mem-
ber of the mitochondrial Rho GTPase family of proteins together
with Miro-2. Our observations on Miro-2 expression levels sug-
gest thatMiro-1 plays unique functions inmitochondrial localiza-
tion that cannot be replaced by Miro-2. Miro-1 localizes at the
outer mitochondrial membrane and has two EF-hand Ca2 bind-
ing domains (13). Our data show, for the first time, that Miro-1
interacts with the dynein/dynactin complex, whereas interaction
of Miro-1 with kinesin was previously described to promote an-
terograde mitochondrial movement (14, 15, 17, 18). This interac-
tion may account for previously described effects on retrograde
mitochondrial movement (48). In this regard, kinesin and dynein
are interdependent in axonal transport (49), interacting directly
through kinesin light chains (50) and indirectly through the same
region of p150glued dynactin (51). These actions coordinate bidi-
rectional movement of organelles along axon microtubules. Re-
cent evidence suggests that kinesin and dynein can interact with
the same mitochondrion, determining its complex mobility pat-
terns in axons (52). Mitochondria can buffer the Ca2 that enters
T lymphocytes via store-operated Ca2 channels (53). A recent
study identifiedMiro-1 as aCa2 sensor involved in the regulation
of mitochondrial mobility in neurons and heart cell lines (16).
Upon Ca2 binding to the EF-hand domains, a conformational
change in Miro-1 provokes the release of mitochondria from mi-
crotubules and their arrest at the subcellular site of calcium influx,
where they can contribute to the cell’s response to this second
messenger (15–17).Miro-1 function has been studied primarily in
FIG5 Miro-1 regulates cell polarity andmitochondrial relocalization toMTOC. (A) Left panel, quantification of elliptical form factor in control (1,213 cells) and
Miro-1-silenced (1,245 cells) CEM T cells plated on a matrix containing CXCL12. Data are shown as a scatter plot. Horizontal lines depict medians from two
independent experiments; ***, P 0.001. Right panels, representative cells from each treatment group. Scale bars, 10 m. (B) Quantification of elliptical form
factor in CEMT cells overexpressing GFP (345 cells), GFP–Miro-1 (512 cells), and GFP-MiroKK (431 cells) and plated on amatrix containing CXCL12. Data are
shown as a scatter plot. Horizontal lines depict medians from two independent experiments; *, P  0.05. (C) 3D reconstruction of mitochondria (red) and
MTOC (-tubulin, green) in control andMiro-1-silenced CEM T cells plated on a matrix containing or lacking CXCL12. Scale bars, 2 m. (D) Graph showing
the distance between mitochondria and MTOC in cells as in panel C. Data are means SEM from two independent experiments; ***, P 0.001 (by one-way
ANOVA). The numbers of cells analyzed for each condition were 73 (siCrtl), 60 (CXCL12 siCtrl), 66 (siMiro), and 64 (CXCL12 siMiro). (E) 3D reconstruction
of GFP proteins (green), mitochondria (red), and MTOC (-tubulin, cyan) in CEM T cells overexpressing GFP, GFP–Miro-1, or GFP-MiroKK and plated on a
matrix containing CXCL12. Scale bars, 2 m. (F) Graph showing the distance between mitochondria and MTOC in cells as in panel D. The numbers of cells
analyzed for each condition were 115 (GFP), 103 (GFP–Miro-1), and 113 (GFP-MiroKK). Data are means SEM from two independent experiments (***, P
0.001; **, P 0.01).
FIG 6 Miro-1 connects mitochondria to the microtubule retrograde transport machinery and regulates CXCL12-induced cytoskeleton activation. (A) Coim-
munoprecipitation analysis showing association of Miro-1 with the dynein motor complex. Complexes (IP) were precipitated from cell lysates of transfected
HEK293 cells (input) with anti-GFP and probed with anti-p74, anti-p50, and anti-GFP (left panel) or from human primary T lymphoblasts with anti-Miro-1
antibody and probed with anti-dynein heavy chain (DHC), anti-p150, and anti-Miro-1 (right panel). (B) Actin polymerization dynamics in control or
Miro-1-silenced CEM T cells exposed to CXCL12. F-actin content was measured by flow cytometry and is expressed relative to time zero. Data are presented as
means  SEM from three independent experiments; ***, P  0.001 (by multifactorial ANOVA). (C) Representative images of F-actin (phalloidin, green),
mitochondria (Mitotracker Orange, red), and ICAM-3 to mark the uropod (cyan) in maximum projections of a confocal Z-stack of CEM T cells plated on a
matrix containing CXCL12. (D) Representative images of pMLCdistribution in control andMiro-1-silenced CEMT cells plated on a CXCL12matrix. Cells were
stained for pMLC (green), Mitotracker Orange (red), and ERM (cyan). The graph shows pMLC fluorescence intensity ratios of the uropod and the leading edge.
Data are shown as a scatter plot. Horizontal lines depict medians from two independent experiments; *, P 0.05.
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neuronal cells, where soma and synaptic structures can be distant
from each other. It is therefore conceivable that mitochondrial
positioning influences synaptic transmission by local ATP pro-
duction and local Ca2 buffering. Although changes ofmitochon-
drial positioning within small spherical cell like lymphocytes may
be more modest (54), the evidence on how mitochondrial mor-
phology and positioning are crucial for cellular signal threshold in
immune cells is emerging (9–12, 43, 55). Our data demonstrate
how changes of only few micrometers in lymphocyte mitochon-
drial positioning to the adhesion zone or to the uropod are able to
significantly affect both adhesion and migration. Unlike lympho-
cytes, migrating epithelial cells require an anterior mitochondrial
localization for correct migration. In these cells, Miro-1 knock-
down also perturbs mitochondrial localization and reduces their
migratory capability (56), in agreement with our data. The mito-
chondrial localization correlates with MTOC localization in leu-
kocytes and epithelial cells (57, 58) and distribution of calcium
levels (59).
Inourmodel, theaccumulationofmitochondria at thecell-to-cell
contact suggests involvement of calcium in the polymerization and
contraction of the actin cytoskeleton. This is in agreementwith the
defect in actin polymerization and in myosin light-chain phos-
phorylation found in Miro-1-silenced cells, correlating with the
deficiency in mitochondrial polarization. These data suggest a
possible function for the accumulation of mitochondria at the
contact zone of the lymphocyte with the endothelium.Mitochon-
dria may indeed supply the ATP necessary for the activity of the
various kinases involved in these processes, as well as for actin
polymerization and MLC phosphorylation required to establish
and maintain persistent cell polarization. During firm adhesion,
the combination of integrin signaling and exposure to immobi-
lized chemokines on the apical surface of endothelial cells induces
a marked change in the leukocyte morphology (60). Miro-1-si-
lenced cells were unable to polarize properly under shear stress
conditions, and these cells as well as MiroKK-expressing cells
showed impaired polarization in response to CXCL12 stimula-
tion, highlighting the importance of Miro-1 in mitochondrial re-
distribution during cell polarization (61). These results indicate
that Ca2 binding might dissociate Miro-1 from the dynein/dyn-
actin complex, as previously described for kinesin interaction (15,
17). However, additional studies are required to demonstrate this.
The loss of mitochondrial accumulation around theMTOC in
Miro-1-silenced cells upon CXCL12 stimulation was accompa-
nied by impairedmigration and transmigration, loss of direction-
ality, reducedCa2 oscillation duringmigration, and inhibition of
ERK1/2 phosphorylation. It is therefore conceivable that Miro-1
regulates, through Ca2 binding to its EF motifs, the redistribu-
tion and relocation of mitochondria around the MTOC at the
uropod, where they not only provide ATP to sustain actomyosin
contraction (9) but also contribute to Ca2 influx at the rear of the
migrating cell. The localized Ca2 influxmay contribute, through
calmodulin-basedmachinery, to the activation of theMLC kinase
required for uropod retraction during migration (62, 63). At the
same time, mitochondrial Ca2 influx can increase ATP produc-
tion by activating the tricarboxylic acid cycle and enhancing the
activities of the electron transport chain enzymes and the ATP
FIG 7 Miro-1 regulates mitochondrion-dependent calcium influx during adhesion and migration. (A) Flow cytometry analysis of intracellular calcium
dynamics (Fluo4-AM staining) in response to the addition of CXCL12 (10 nM) to a suspension of control andMiro-1-silencedCEMT cells (prestainedwithDiD
andDiL, respectively). Results from a representative experiment out of three performed are shown. (B) Representative intracellular calciumoscillation in control
andMiro-1-silenced CEMT cells migrating on TNF--activatedHUVEC. (C) Distribution of relative calcium peak intensity (left) and peak duration in seconds
(right). Data are shown as a scatter plot; horizontal lines depict medians from two independent experiments (67 control and 62Miro-1-silenced cells) (***, P
0.001). (D) Amounts of ATP in unstimulated and CXCL12-stimulated (10 min) control andMiro-1-intefered cells. Data are means SEM from two indepen-
dent experiments. ***, P 0.001; *, P 0.05 (by one-way ANOVA). (E) Time course of the phosphorylation status of ERK1/2 in control and Miro-1-silenced
CEMT cells activated with CXCL12. Total protein expression is shown as a loading control. The right panel shows pERK/total ERK band intensity ratios relative
to the ratio in control cells at t 0. Data are presented as the means SD from two independent experiments.
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synthase complex (64). Whether the impaired mitochondrial re-
distribution to the uropod caused by Miro-1 downregulation is
able to reduce Ca2 entry at this subcellular location remains to be
elucidated. Nevertheless, we cannot rule out that Miro-1 might
play additional roles unrelated to mitochondrial positioning that
might contribute to its effects on actin polymerization, calcium
oscillations, and cell migration.
In summary, we demonstrate thatMiro-1 can contribute to the
regulation ofmitochondrial translocation toward theMTOCdur-
ing lymphocyte adhesion to the inflamed endothelium and the
subsequent directed migration toward the site of inflammation,
demonstrating the importance ofmitochondrial subcellular local-
ization in these processes. Considering the importance of an ap-
propriate and rapid recruitment of leukocytes for an efficient im-
mune response, our results shed new light about the regulation of
adhesion and migration processes that could help the design of
new, more specific strategies for the treatment of a large variety of
immunological diseases in which there is deregulated leukocyte
recruitment.
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